logo for VaxEquity

VaxEquity

Chemicals & Related Products · United States · <25 Employees

View Company Info for Free

About

Headquarters

United States

Revenue

<$5 Million

Industry

Chemicals, Petrochemicals, Glass & Gases Manufacturing

Who is VaxEquity

VaxEquity is a biotechnology company amplifying the impact of RNA vaccines and therapeutics, through using its next generation self-amplifying RNA (saRNA) platform. The Company uses saRNA to provide greatly enhanced protein expression, combining better tolerability with slower release and thermostability. VaxEquity is pioneering a next generation approach by modifying its saRNA to modulate the immune response and thereby overcoming current limitations. The flexibility of the Companys platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. VaxEquity was founded in 2020 by Professor Robin Shattock, the Head of Immunology of Infection at Imperial College London and is led by a world class team who are pioneers in the field of RNA.Read more

VaxEquity's Social MediaPopular SearchesVaxEquity LtdVaxEquityVaxEquity Ltd CoSIC Code 28,283NAICS Code 32,325Show more

VaxEquity Org Chart

PhoneEmail
Graham Dowsett

PhoneEmail
George Dakar

PhoneEmail

PhoneEmail

Is VaxEquity your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to VaxEquity

See more similar companies
Illustration of an envelope

VaxEquity Tech Stack

A closer look at the technologies used by VaxEquity

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

VaxEquity News & Media

Read more news

Frequently Asked Questions regarding VaxEquity

Where is VaxEquity located?
VaxEquity's headquarters are located at United States
What is VaxEquity's official website?
VaxEquity's official website is www.vaxequity.com
What is VaxEquity's Revenue?
VaxEquity's revenue is <$5 Million
What is VaxEquity's SIC code?
VaxEquity's SIC: 28,283
What is VaxEquity's NAICS code?
VaxEquity's NAICS: 32,325
How many employees does VaxEquity have?
VaxEquity has <25 employees
What industry does VaxEquity belong to?
VaxEquity is in the industry of: Chemicals, Petrochemicals, Glass & Gases, Manufacturing
What is VaxEquity competition?
VaxEquity top competitors include: Pappas Ventures companies, The Column Group, Boehringer Ingelheim Venture Fund, Dren Bio
What technology does VaxEquity use?
Some of the popular technologies that VaxEquity uses are: reCAPTCHA, PHP, Mapbox GL JS API, Adobe Typekit
What does VaxEquity do?

VaxEquity is a biotechnology company amplifying the impact of RNA vaccines and therapeutics, through using its next generation self-amplifying RNA (saRNA) platform. The Company uses saRNA to provide greatly enhanced protein expression, combining better tolerability with slower release and thermostability. VaxEquity is pioneering a next generation a... pproach by modifying its saRNA to modulate the immune response and thereby overcoming current limitations. The flexibility of the Companys platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. VaxEquity was founded in 2020 by Professor Robin Shattock, the Head of Immunology of Infection at Imperial College London and is led by a world class team who are pioneers in the field of RNA.Read More

What are VaxEquity social media links?
VaxEquity Linkedin page VaxEquity Twitter page
Is VaxEquity a public company?
VaxEquity is private company therefore does not currently have an official ticker symbol
See more information about VaxEquity

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.